Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| AU565 | Ulixertinib | 0.316227766 | 0.9745 | -0.00064 |
| AU565 | Ulixertinib | 0.316227766 | 0.7564 | 0.00838 |
| AU565 | Ulixertinib | 1.0 | 0.9875 | 0.00423 |
| AU565 | Ulixertinib | 1.0 | 0.9780 | 0.02367 |
| AU565 | Ulixertinib | 1.0 | 0.9035 | -0.00147 |
| AU565 | Ulixertinib | 3.16227766 | 0.8926 | 0.03770 |
| AU565 | Ulixertinib | 3.16227766 | 0.7558 | -0.00182 |
| AU565 | Ulixertinib | 3.16227766 | 0.7230 | 0.00498 |
| AU565 | Ulixertinib | 10.0 | 0.4582 | 0.03572 |
| AU565 | Ulixertinib | 10.0 | 0.5262 | 0.05536 |
| AU565 | Ulixertinib | 10.0 | 0.5814 | 0.03147 |
| AU565 | Alvocidib | 0.0001 | 1.1288 | -0.00899 |
| AU565 | Alvocidib | 0.0001 | 0.8489 | 0.00936 |
| AU565 | Alvocidib | 0.0001 | 1.1463 | -0.01951 |
| AU565 | Alvocidib | 0.000316228 | 0.9524 | -0.01050 |
| AU565 | Alvocidib | 0.000316228 | 1.0164 | 0.00146 |
| AU565 | Alvocidib | 0.000316228 | 1.1956 | 0.00605 |
| AU565 | Alvocidib | 0.001 | 0.8563 | 0.01723 |
| AU565 | Alvocidib | 0.001 | 0.9434 | 0.03923 |
| AU565 | Alvocidib | 0.001 | 0.8944 | -0.01480 |
| AU565 | Alvocidib | 0.003162278 | 0.8034 | 0.00939 |
| AU565 | Alvocidib | 0.003162278 | 0.9434 | 0.00863 |
| AU565 | Alvocidib | 0.003162278 | 0.7223 | -0.01420 |
| AU565 | Alvocidib | 0.01 | 0.9887 | 0.01116 |
| AU565 | Alvocidib | 0.01 | 0.9958 | -0.00712 |